D. Yarnall

发表

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

A. J. Slater, Rachel L. Taylor, P. Matthews, 2008, Archives of neurology.

Direct sequencing of bacterial and P1 artificial chromosome-nested deletions for identifying position-specific single-nucleotide polymorphisms.

J. Riley, D. Yarnall, H. E. Davies, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Muscle Rad Expression and Human Metabolism: Potential Role of the Novel Ras-Related GTPase in Energy Expenditure and Body Composition

D. Yarnall, W. Garvey, P. Wallace, 1997, Diabetes.

Identification of Rad's effector‐binding domain, intracellular localization, and analysis of expression in Pima Indians

D. Yarnall, R. Pratley, W. Garvey, 1997, Journal of cellular biochemistry.

Elevated levels of TNF in the joints of adjuvant arthritic rats.

T. Smith-Oliver, D. Yarnall, K. Connolly, 1993, Cytokine.

Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments

W. J. Cromartie, D. Yarnall, R. Clark, 1987, Infection and immunity.

Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/c-Jun-amino-terminal kinase interacting protein-1 (JIP-1) gene.

V. Mooser, G. Waeber, D. Yarnall, 1999, Genomics.

Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9.

D. Yarnall, M. Boyle, 1986, Molecular immunology.

Anti‐inflammatory activity of phosphodiesterase (PDE)‐IV inhibitors in acute and chronic models of inflammation

D. Yarnall, R. Clark, J. A. Menius, 1995, Clinical and experimental immunology.

Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B).

D. Yarnall, J. McGarry, D. W. Foster, 1997, Genomics.

Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families

A. F. Scott, K. Barnes, D. Yarnall, 2006, Genes and Immunity.

A single-nucleotide polymorphism tagging set for human drug metabolism and transport

Nicole Soranzo, Nicholas W Wood, David B Goldstein, 2005, Nature Genetics.

Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene.

C. Yen, D. Yarnall, A. Shuldiner, 1997, Biochemical and biophysical research communications.

Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation

K. Silver, C. Yen, D. Yarnall, 1997 .

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

K. Silver, C. Yen, D. Yarnall, 1997, Biochemical and biophysical research communications.

Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.

D. Yarnall, J. Taylor, A. B. Strickland, 1995, The Journal of pharmacology and experimental therapeutics.

Genomic characterization of the coding region of the human type II 5′-deiodinase gene

D. Yarnall, A. Shuldiner, G. Canettieri, 1998, Molecular and Cellular Endocrinology.

Case‐control single‐marker and haplotypic association analysis of pedigree data

Sharon R. Browning, Gyan Chandra, Andrew J. Karter, 2005, Genetic epidemiology.

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial

L. Schneider, C. Lyketsos, A. Monsch, 2019, Alzheimer's & dementia.